We are live on ! Find out more
ASTH icon

Astrana Health

36 hedge funds and large institutions have $50.4M invested in Astrana Health in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

13% more funds holding

Funds holding: 3236 (+4)

1.02% less ownership

Funds ownership: 7.83%6.81% (-1%)

25% less capital invested

Capital invested by funds: $67.5M → $50.4M (-$17.1M)

56% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 16

Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
7
Reduced
16
Closed
5
Calls
Puts
Net Calls
Net Calls Change

ASTH Hedge Fund Activity: Q3 2018 in Review

36 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2018, worth a combined $50.4M — down 25% from $67.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ASTH positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 16 trimmed.

The largest buyer was Vanguard Group, adding an estimated $12.7M. The largest seller was BlackRock, cutting an estimated $16.2M.

  • 36 institutional investors held Astrana Health (ASTH) as of Q3 2018, up from 32 in Q2 2018.
  • Funds reported $50.4M of Astrana Health stock for Q3 2018, down 25% quarter-over-quarter.
  • 9 funds opened new Astrana Health positions in Q3 2018 and 5 closed out, a net change of +4 holders.
  • The largest Astrana Health buyer in Q3 2018 was Vanguard Group, an estimated $12.7M added.
  • The largest Astrana Health seller in Q3 2018 was BlackRock, an estimated $16.2M sold.

Based on aggregated 13F filings for Q3 2018.